HealthDay.com
COVID-19 Case Fatality Rate Increased for Cancer Patients
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively
FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
April 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2020. This roundup includes the latest...
April 2020 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for April 2020. This roundup includes the...
April 2020 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for April 2020. This roundup includes the latest...
April 2020 Briefing – Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for April 2020. This roundup includes the...
April 2020 Briefing – Anesthesiology
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for April 2020. This roundup includes the latest...
April 2020 Briefing – Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for April 2020. This roundup includes the latest...
April 2020 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for April 2020. This roundup includes the latest...
April 2020 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for April 2020. This roundup includes the latest...
